Abstract
Approximately 60% of septic patients developed acute kidney injury (AKI). The mortality rate of septic AKI (SA-AKI) is two to three times higher than that of septic without AKI (SA-non-AKI). The actual functions and mechanisms of CircRNAs in the pathophysiology of SA-AKI remain incompletely understood. Herein, we observed that the mmu_Circ_26986 could be induced by lipopolysaccharide (LPS) and cecum ligation and puncture (CLP) in BUMPT cell line and C57BL/6 mouse kidney, respectively. Functionally, mmu_Circ_26986 suppressed BUMPT cell apoptosis induced by LPS. Mechanistically, mmu_Circ_26986 sponged miRNA-29b-1-5p to upregulate the expression of PAK7. Overexpression of mmu_Circ_26986 ameliorated the progression of CLP-stimulated AKI through miRNA-29b-1-5p/PAK7 axis. In addition, we found that hsa_Circ_0072463, homologous to mmu_Circ_26986, suppressed LPS-induced HK-2 cells apoptosis via regulation of miRNA-29b-1-5p/PAK7 axis. Furthermore, sepsis patients with AKI had a higher level of hsa_Circ_0072463 compared to those without AKI. The sensitivity, specificity and AUC of hsa_Circ_0072463 were 78.8%, 87.9% and 0.866, respectively. Spearman's test indicated a noticeable positive correlation between plasma hsa_Circ_0072463 and serum creatinine in sepsis patients (r = 0.725). In summary, this study reveals that the mmu_Circ_26986/hsa_Circ_0072463 miRNA-29b-1-5p/PAK7 axis mediates septic AKI, and hsa_Circ_0072463 is a potential diagnostic marker for septic AKI.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Approximately 60% of patients with sepsis suffer from sepsis-associated acute kidney injury (SA-AKI), exacerbating sepsis morbidity and mortality [1]. Therefore, it is crucial to early identify SA-AKI and investigate its underlying mechanism [2]. Recent data have identified more than ten proteins, such as TIMP2 and IGFBP7, with potential diagnosis values for SA-AKI [3,4]. Additionally, three underlying mechanisms, including microcirculatory dysfunction [5], inflammation [6], and metabolic reprogramming [7], contribute to the progression of SA-AKI. However, there is currently no effective treatment method other than kidney replacement therapy to prevent the progression of SA-AKI [8,9,10]. Hence, our goal is not only to explore the pathophysiology of SA-AKI, but also to identify better early biomarkers for it. The significant aspect is that the new molecule serves as both an intervention target and a potential biomarker for SA-AKI.
Circular RNAs (CircRNAs), a specific class of RNA molecules, belong to non-coding RNAs (ncRNAs) [11]. In comparison with linear RNAs, CircRNAs exhibit greater stability, possess a longer lifespan, and demonstrate resistance to RNase R, making them ideal biomarkers for human diseases [12,13]. Moreover, CircRNAs are responsible for the progression of various diseases and have become therapeutic targets [14]. Recent research has identified several CircRNAs responsible for the progression of SA-AKI [15]. Only one study has indicated that Circ_0020339 promotes the development of SA-AKI and acts as a diagnostic marker [16]. In this study, we focus on mmu_Circ_26986, located in Arl15, whose role and diagnostic value in SA-AKI remain largely unclear.
Our study indicated that lipopolysaccharide (LPS) and cecum ligation and puncture (CLP) could induce the expression of mmu_Circ_26986 both in cell and animal experiments. Mmu_Circ_26986 suppressed LPS-stimulated apoptosis in BUMPT cells by targeting the miRNA-29b-1-5p/PAK7 axis. CLP-induced SA-AKI in mice was ameliorated by the overexpression of mmu_Circ_26986. Finally, we found that hsa_Circ_0072463, homologous to mmu_Circ_26986, serves as an early diagnostic marker for SA-AKI.
Materials and methods
Antibodies and reagents
Anti-PAK7 and anti-β-tubulin antibodies were procured from Proteintech (USA). Anti-C3 (9662) and CC3 (9664) antibodies were supplied by Cell Signaling Technology (USA). Secondary antibodies were obtained from Affinity (USA). FITC-Annexin-V-Apoptosis-Detection-Kit-I (556,547; BD Pharmingen, USA); luciferase-assay-kit (BioVision, USA); AG-SYBR-Green-Pro-Taqhs-premix (Accurate Biotechnology, China); LPS (L2880; Sigma, USA).
Cell culture and treatment
BUMPT and HK-2 cell lines were cultured with DMEM (Sigma-Aldrich) containing 10% FBS and 1% penicillin–streptomycin at 37 °C and 5% CO2, and then treated with LPS for 24 h at 300 mg/mL or 50 mg/mL, respectively. Cells were transfected with mmu_Circ_26986 siRNA (100 nM) or plasmid, hsa_Circ_0072463 plasmid (1 ug/ml), miRNA-29b-1-5p mimic (100 nM), miRNA-29b-1-5p inhibitor (100 nM), PAK7 siRNA, or negative control (Ruibo, China) using Lipofectamine-2000 (Life Technologies, USA).
Animal models
Circ_26986 or control expression vectors (25 μg DNA/injection) were administered through the tail vein of C57BL/6 J male mice (8–10 weeks old), and then subjected to CLP, saline injection as a sham operation as a control, respectively. Kidney tissues were acquired for assessing renal morphology and function at 18 h after CLP treatment. The study involved animal testing in adherence to the guidelines set by the Institutional Committee for the Care and Use of Laboratory Animals at the Second Xiangya Hospital. Throughout the experiments, the animals were provided unrestricted access to standard water and food and followed a 12-h light–dark cycle.
Cecum ligation and puncture model
C57 mice weighing 21–25 g were selected and fasted for 12 h before surgery. After anaesthesia was administered by intraperitoneal injection according to body weight, the animals were fixed supine on a surgical plate, the abdominal surgical regions were routinely disinfected and dehairing was performed, and a 2-cm-long incision was made on the abdominal wall with a scalpel in aseptic conditions. An 18-gauge needle was used to perforate the ligated end and a small amount of faeces was squeezed out, avoiding damage to the blood vessels as much as possible, and then the skin and peritoneum were closed intermittently with a 4-gauge silk suture, while 50 ml/kg saline was injected for antishock.
qRT-PCR analysis
Trizol Reagent (Invitrogen) was utilized for total RNA extraction from BUMPT cells, HK-2 cells, and kidneys of C57BL/6 J mice. Next, approximately 40 ng of total RNA was reverse transcribed to cDNA using the Prime-Script-RT-Reagent-Kit and the gDNA-Eraser-Kit (RR047A; TaKaRa, Japan). qRT-PCR and SYBR Green (AG11728; Accurate Biotechnology (HUNAN) CO., LTD, ChangSha China) were employed to detect the expression levels of circRNA, micoRNA, and target gene mRNA. Relative quantification was performed by Roche LC 480 determination of ΔCt values (F. Hoffmann-La Roche, Ltd.).
Primers:
Circ_26986 (F: GAACGAACTGCACTCCGCTCTC, R: GCTGCTGGCTTGTCTTGATGATTG)
miRNA-29b-1-5P (F: GCACCGTGCTGGTTTCATATGG, R: ATCCAGTGCAGGGTCCGAGG
RT primer: ATCCAGTGCAGGGTCCGAGG)
hsa_Circ_0072463 (F: TTCCGATGACCAGTTACACAA, R: TTGGTAGTAGCGGCTCCAGT)
PAK7 (F: CTGGGAGAGGTTTGGGAGGAGAG, R: AGGGAACTACTACGGCTGGGAAG)
U6 (F: AGAGAAGATTAGCATGGCCCCTG, R: CAGTGCAGGGTCCGAGGT)
Endogenous Reference Human (F: CCTGGCACCCAGCACAAT, R: GGGCCGGACTCGTCATA)
Endogenous Reference Mouse (F: GGCTGTATTCCCCTCCATCG, R: CCAGTTGGTAACAATGCCATGT)
FISH analysis
BUMPT cell line or kidney tissues were fixed with paraformaldehyde for 5 min and then permeabilized with prehybridization solution and hybridization solution. Mmu_Circ_26986 fluorescent probe and miRNA-29b-1-5p fluorescent probe (Ruibo, China) were hybridized overnight at 37°. On the next day, nuclei were blocked and stained with DAPI, followed by fluorescence imaging analysis using a laser scanning confocal microscope. U6 nuclear positivity and 18S rRNA cytoplasmic positivity were used for references.
Immunoblot analysis
Briefly, about 30 ng proteins were separated through SDS-PAGE followed by the transfer using 0.22 nm PVDF membrane (Amersham, UK). The membranes were exposed to primary antibody pak7 (1:1000 dilutiofoon), C3 (1:2000 dilution), CC3 (1:1000 dilution), and β-tubulin (1:2000 dilution) for 4°overnight, and then exposed to secondary antibody for 1 h. After PBST washing, the membranes were developed with ECL reagent. β-tubulin is an internal control.
Flow cytometry assessment
Annexin V-FITC/PI staining was performed to determine apoptosis. Briefly, BUMPT or HK-2 cell lines were harvested and resuspended with binding buffer, and subsequently stained with annexin V-FITC and PI. After incubation for 15 min in the dark, 200 uL of binding buffer was added and examined using a Northern Light flow meter (Cytek Biosciences). Apoptosis rate was the percentage of late apoptotic (AnnexinV + /PI +) and early apoptotic (AnnexinV + /PI-) cells to cells.
Luciferase reporter assays
The DLR of WT-Luc-PAK7, WT-Luc-Circ_26986, MUT1-Luc-PAK7, MUT2-Luc-PAK7 and MUT-Circ_26986 plasmids were established by Tsingke Biotechnology (Beijing, China), and then co-transfected with miRNA-29–1-5p mimics into BUMPT cell lines for 48 h. Luciferase activity was examined using SpectraMax M5 (Molecular Devices, USA) following normalization with pGMLR-TK as an internal reference.
Renal function, morphology, and TUNEL staining
The concentrations of BUN and creatinine were detected (Nanjing Jianjian Bioengineering Research Institute, China). H&E staining was used to evaluate the degree of renal tubular injury: renal tubules were markedly dilated and cellular flattening was scored as 1 point; brush border injury was scored as 1 point, detachment was scored as 2 points; titularity was scored as 2 points; and the presence of detached, necrotic cells in the lumen of renal tubules (which did not become tubular or cellular debris) counted as 1 point. TUNEL staining was applied to determine renal cell apoptosis, positively stained cells were counted and stained samples were evaluated using Zeiss microscope-equipped software.
Human samples
The definition and grading of SA-AKI were referred to the consensus guidelines and KDIGO criteria, respectively. Human blood was collected from healthy volunteers (n = 33), SA-non-AKI patients (n = 33), and SA-AKI patients (n = 33), and then centrifuged to extract plasma or serum, followed by storage at -80°. The research methodology received approval from the Second Review Committee of Xiangya Hospital, People's Republic of China. Prior to participation, all individuals provided informed consent for their involvement in the study.
Statistical analysis
GraphPad Prism 9.4 was utilized for statistical analyses. All values are shown as mean ± SD. Differences between two or more groups were examined with Student's T-test or one-way ANOVA followed by Tukey's post-hoc test. ROC curve analysis was also performed using GraphPad. The relationship between Circ and creatinine was analyzed by Spearman's correlation coefficients.
Results
Mmu_Circ_26986 expression is elevated in LPS-induced BUMPT cells and CLP-induced mice AKI
We examined the expression of mmu_Circ_26986 in BUMPT cell line and C57BL/6 mouse model induced by LPS and CLP, respectively. Firstly, qRT-PCR data unveiled that mmu_Circ_26986 was highly expressed at 6 h, gradually increased at 12 h, and peaked at 24 h (Fig. 1A). Secondly, to determine the in vivo expression of mmu_Circ_26986, a sepsis animal model was constructed by CLP in C57BL/6 J mice. Renal function detection indicated a slight increase in BUN and Creatinine induced by CLP at 6 h, reaching a peak at 18 h (Fig. 1B, C). H&E and TUNEL staining verified that CLP gradually exacerbated renal tubular injury and apoptosis at 6 h and 18 h (Fig. 1D-G). The qRT-PCR data also showed that mmu_Circ_26986 was highly expressed at 9 h and peaked at 18 h (Fig. 1H). Correlation analysis revealed a high correlation between the mmu_Circ_26986-fold change (R = 0.957) and the renal cell apoptosis rate (Fig. 1I). FISH analysis demonstrated that mmu_Circ_26986 mainly localized in the cytoplasm of BUMPT and mouse kidney tubular cell lines (Fig. 1J). These findings imply that mmu_Circ_26986 is related to the progression of SA-AKI.
Downregulation of mmu_Circ_26986 enhances LPS-stimulated BUMPT cell apoptosis
To determine the functions of mmu_Circ_26986 in BUMPT cell apoptosis after LPS treatment, mmu_Circ_26986 with siRNA was used. qRT-PCR analysis indicated that mmu_Circ_26986 siRNA suppressed its expression levels under LPS and basal conditions (Fig. 2A). Flow cytometry analysis demonstrated that mmu_Circ_26986 siRNA exaggerated LPS-stimulated BUMPT cell death (Fig. 2B&C), and this effect was verified by the immunoblotting results of cleaved-caspase3 (CC3) (Fig. 2D&E). These results suggest that mmu_Circ_26986 has an anti-apoptotic function during LPS treatment.
Mmu_Circ_26986 overexpression ameliorates LPS-stimulated BUMPT cell apoptosis
To further support the above findings, the mmu_Circ_26986 plasmid was applied. qRT-PCR data indicated that overexpression of mmu_Circ_26986 upregulated its expression under LPS and basal conditions (Fig. 3A). Flow cytometry analysis showed that overexpression of mmu_Circ_26986 attenuated LPS-stimulated BUMPT cell death (Fig. 3B&C), and this effect was further verified by the immunoblotting results of CC3 (Fig. 3 D&E). These findings further confirm the data of mmu_Circ_26986 siRNA knockdown experiments.
MiRNA-29b-1-5p is sponged by mmu_Circ_26986
As mmu_Circ_26986 is overexpressed in the cytoplasm of BUMPT cells (Fig. 1J), we hypothesize that mmu_Circ_26986 may act as a miRNA sponge to modulate the expression of target genes. We found that Mmu_Circ_26986 contains a complementary binding site for miRNA-29b-1-5p via RegRNA v2.0 predication (Fig. 4A). Analysis of the luciferase reporter gene assay indicated that the miRNA-29b-1-5p mimic noticeably suppressed luciferase activity in the mmu_Circ_26986-wild-type (WT), while this effect was not observed in the mmu_Circ_26986-mutant (MUT) (Fig. 4B). Moreover, co-localization experiments indicated that mmu_Circ_26986 could interact with miRNA-29b-1-5p in the cytoplasm of basal and LPS-stimulated BUMPT cells as well as renal tubular cells of sham and CLP mice (Fig. 4C, D). Furthermore, qRT-PCR analysis demonstrated that LPS reduced the expression of miRNA-29b-1-5p, and this effect was enhanced and attenuated by the knockdown and overexpression of mmu_Circ_26986, respectively (Fig. 4E, F). Altogether, these data suggest that miRNA-29b-1-5p is a target of mmu_Circ_26986.
MiRNA-29b-1-5p mimic exacerbates LPS-stimulated BUMPT cell apoptosis
Previous study has demonstrated the pro-apoptotic properties of miRNA-29b-1-5p in cardiomyocytes [17], but its role in renal cells apoptosis remains completely unknown. The qRT-PCR data indicated that miRNA-29b-1-5p mimic upregulated its expression under LPS and basal conditions (Fig. 5A). Flow cytometry analysis showed that miRNA-29b-1-5p mimic enhanced LPS-stimulated BUMPT cell death (Fig. 5B, C), and this effect was further validated by immunoblotting of CC3 (Fig. 5D, E). Thus, the findings suggest that miRNA-29b-1-5p is an apoptosis inducer.
PAK7 is a target gene of miRNA-29b-1-5p
Several studies have reported that PAK7 exhibits anti-apoptotic functions in many cells [18,19]. However, its role in renal cells remains unclear. Interestingly, PAK7 was predicted to be a target gene of miRNA-29b-1-5p using miRDB database. The sequence analysis demonstrated that miRNA-29b-1-5p encompassed a complementary sequence of PAK7 (Fig. 6A). The luciferase reporters found that the miRNA-29b-1-5p mimic could suppress the luciferase activity of PAK7-WT but not PAK7-MUT (Fig. 6B). qRT-PCR and immunoblotting analysis revealed that miRNA-29b-1-5p mimic obviously decreased the mRNA/protein expression level of PAK7 (Fig. 6C–E). Flow cytometry analysis indicated that PAK7 siRNA remarkably increased LPS-stimulated BUMPT cell apoptosis (Fig. 6F, G), and this effect was verified by immunoblotting analysis of PAK7 downregulation and CC3 upregulation (Fig. 6H, I). This study confirms that PAK7 is a direct target gene of miRNA-29b-1-5p.
We further elucidated the mechanism underlying the anti-apoptotic action of PAK7 in BUMPT cell line. Immunoblot analysis showed that PAK7 siRNA reduced the expression of wnt and β-catenin, but promoted the expression of p- β-catenin (Supplement Fig. 1). These results demonstrate that PAK7 may play an anti-apoptotic role through the wnt/β-catenin pathway.
The pro-apoptotic effect of mmu_Circ_26986 siRNA on BUMPT cell line upon LPS injury is reversed by miRNA-29b-1-5p inhibitor
We further confirmed whether miRNA-29b-1-5p mediated the anti-apoptotic effect of mmu_Circ_26986 during LPS treatment. The inhibition efficiencies of mmu_Circ_26986 siRNA and miRNA-29b-1-5p inhibitor were evaluated by qRT-PCR (Fig. 7A&B). Flow cytometry analysis showed that mmu_Circ_26986 knockdown enhanced LPS-stimulated apoptosis in renal cells, which could be reversed by the miRNA-29b-1-5p inhibitor (Fig. 7C&D). Immunoblotting results of the changes in cleaved-caspase-3 and PAK7 further supported the flow cytometry data (Fig. 7E&F). The findings further verified that mmu_Circ_26986 suppressed LPS-stimulated renal cell apoptosis via the miRNA-29b-1-5p/PAK7 axis.
Overexpression of mmu_Circ_26986 attenuates SA-AKI in mice by regulating the miRNA-29b-1-5p/Pak7 axis
To better evaluate the functions of mmu_Circ_26986 in SA-AKI, C57BL/6 J mice were exposed to mmu_Circ_26986 overexpression plasmid for 12 h via tail vein and then subjected to CLP treatment. Overexpression of mmu_Circ_26986 markedly suppressed CLP-induced elevation of serum creatinine and BUN (Fig. 8A, B). Consistently, H&E and TUNEL staining results demonstrated that overexpression of mmu_Circ_26986 attenuated CLP-induced renal tubule damage of outer medullary cortex and outer stripe (OSOM) (Fig. 8C, F, D, G) and renal cell apoptosis (Fig. 8E, H). The overexpression of mmu_Circ_26986 markedly increased mmu_Circ_26986 mRNA expression, while suppressed miRNA-29b-1-5p expression (Fig. 8I, J). Immunoblotting results showed that overexpression of mmu_Circ_26986 suppressed CLP-stimulated expression of PAK7 and cleaved-caspase-3 (Fig. 8K, L). Collectively, our study reveals that overexpression of mmu_Circ_26986 prevents the progression of SA-AKI mice via the miRNA-29b-1-5p/PAK7 axis.
Overexpression of hsa_Circ_0072463 inhibits LPS-stimulated HK-2 cell apoptosis
To further explore whether mmu_Circ_26986 has a homology with human CircRNA, the Circbase database was used. We found that mmu_Circ_26986 with homology hsa_Circ_0072463 was the most likely target (Fig. 9A). We further investigated the expression of hsa_Circ_0072463 upon LPS exposure. The qRT-PCR results demonstrated that hsa_Circ_0072463 was overexpressed at 6 h and peaked at 24 h (Fig. 9B). To validate the function of hsa_Circ_0072463, hsa_Circ_0072463 plasmid was transfected into HK-2 cell line and subsequently exposed to LPS. The qRT-PCR data revealed that overexpression of hsa_Circ_0072463 increased its expression but reduced miRNA-29b-1-5p expression under the basal and LPS conditions (Fig. 9C, D). The flow cytometry analysis results showed that hsa_Circ_0072463 overexpression noticeably ameliorated LPS-stimulated HK-2 cell death (Fig. 9E, F), which was validated by the immunoblot analysis of CC3 protein downregulation and PAX7 upregulation (Fig. 9G, H). These findings imply that hsa_Circ_0072463 shares the same function and mechanism with mmu_Circ_26986 during LPS stimulation.
Homologous hsa_Circ_0072463 of mmu_Circ_26986 is a biomarker of SA-AKI
To evaluate whether plasma hsa_Circ_0072463 could act as a diagnostic marker in patients with SA-AKI, we collected the plasma specimens from SA-AKI patients (n = 33), non-AKI patients (n = 33), and age-matched healthy subjects (n = 33), and the expression of hsa_Circ_0072463 was then analyzed. Absolute RT-PCR evaluation indicated that the expression of hsa_Circ_0072463 was induced in septic non-AKI compared with controls, and its expression was higher in sepsis patients than in septic non-AKI patients (Fig. 10A). The clinical features of SA-AKI and non-SA-AKI patients as well as age-matched healthy subjects (n = 99) are shown in Supplement Table 1. We further assessed the diagnostic potential of hsa_Circ_0072463 by generating a subject work characteristics (ROC) curve. The sensitivity, specificity and AUC of plasma hsa_Circ_0072463 were 78.8%, 87.9% and 0.866 (95% confidence interval 0.775–0.957), respectively (Fig. 10B). Interestingly, the expression level of plasma hsa_Circ_0072463 in KIDGO stage2 was higher compared to KIDGO stage1. However, its expression level in KIDGO stage3 was not significantly increased compared to KIDGO stage2 (Fig. 10C). Spearman's correlation coefficient showed the positive correlation between plasma hsa_Circ_0072463 levels and serum creatinine (Fig. 10D). In summary, hsa_Circ_0072463 may function as an early diagnostic marker for SA-AKI.
Discussion
The mounting evidence suggests that CircRNAs are responsible for the development of SA-SKI [15,20,21,22]. In our research, we demonstrated for the first time that mmu_Circ_26986 has a protective effect against LPS-stimulated BUMPT cell apoptosis (Figs. 2, 3). Mechanistically, Mmu_Circ_26986 acts as a ceRNA, targeting miRNA-29b-1-5p to enhance the expression of the antiapoptotic protein PAK7. Overexpression of mmu_Circ_26986 effectively hinders the progression of CLP-induced SA-AKI (Fig. 8). Furthermore, we identified hsa_Circ_0072463, the homologous of mmu_Circ_26986, as an early diagnosis biomarker for SA-AKI (Fig. 10).
Previous reports have highlighted the significant role of CircRNAs in mediating in renal tubular cell apoptosis during sepsis injury [23,24]. Various CirRNAs such as Circ_35953, Circ_HIPK3, Circ_0114427, CIRC_0114428, Circ_0001714, circ_0020339, Circ_RASGEF1B, Circ_0114428, circ-FANCA, CircNRIP1, circ0001818, and Circ_0001806 [16,23,25,26,27,28,29,30,31,32,33,34] have been implicated in LPS-induced renal tubular cell apoptosis. Conversely, others such as CircITCH, CircVMA21, CIRC_0008882, and Circ_0091702 [35,36,37,38] exhibit an opposing role. In our present study, we highlight the antiapoptotic role of mmu_Circ_26986, substantiated by both overexpression and knockdown experiments (Figs. 2, 3). Our data strongly support the notion that mmu_Circ_26986 possesses anti-apoptotic potential.
CircRNAs are known to act as sponges for microRNAs in the cytoplasm, thereby increasing the expression of downstream genes [39,40,41]. The FISH analysis showed that mmu_Circ_26986 predominantly localized in the cytoplasm (Fig. 1). Next, we predicated and verified that miRNA-29b-1-5p could be directly targeted mmu_Circ_26986 (Fig. 4). However, the function of miRNA-29b-1-5p in apoptosis has been a subject of controversy. While one study reported its suppression of LPS-induced apoptosis in MH-S cells [41], another indicated its involvement in mediating apoptosis in hydrogen peroxide-treated cells by targeting Bcl2 [42]. Our data align with the latter, demonstrating that miRNA-29b-1-5p mediates renal tubular cells apoptosis via targeting p21-activated kinase 7 (PAK7) (Fig. 6). Previous studies have reported that PAK7 exerts an antiapoptotic function in multiple tumor cell lines [43,44,45]. Similarly, our findings show that PAK7 knockdown enhances LPS-induced apoptosis in BUMPT cells through the Wnt/β-catenin pathway (Fig. 6). The mmu_Circ_26986/miRNA-29b-1-5p/PAX7 axis was further validated through in vitro recovery experiments and in vivo overexpression of mmu_Circ_26986 (Fig. 8). Collectively, our study indicates that the mmu_Circ_26986/miRNA-29b-1-5p/PAK7 axis plays a pivotal role in the development of SA-AKI.
A recent study highlighted circ_0020339 as an early diagnostic marker for SA-AKI, but the methodology lacked sensitivity and specificity calculations [16]. In our research, we identified, for the first time, a homologue of mmu_Circ_26986, hsa_Circ_0072463, which mediates LPS-stimulated HK-2 cell apoptosis through the regulation of the miRNA-29b-1-5p/PAK7 axis. Furthermore, we validated hsa_Circ_0072463 as an early diagnostic marker for SA-AKI, as supported by its higher sensitivity of 78.79%, higher specificity of 87.88%, and a stronger correlation with serum creatinine (a conventional diagnostic marker of kidney injury) (Fig. 10). However, it is important to note that our study is limited by the sample size, and future research should expand the cohort to further explore the diagnostic potential of hsa_Circ_0072463 for SA-AKI.
In conclusion, our data reveal that mmu_Circ_26986/hsa_Circ_0072463 exerts an anti-apoptotic function by targeting the miRNA-29b-1-5p/PAK7 axis. These CircRNAs hold promise as therapeutic targets for SA-AKI, with hsa_Circ_0072463 emerging as a reliable biomarker for the condition (see Fig. 11).
Data Availability
Primary data will be available from the authors upon request.
Availability of data and materials
All data supporting the findings of this study are available within the paper and its Supplementary Information.
Abbreviations
- AKI:
-
Acute kidney injury
- AUC:
-
The area under the ROC curve
- BUMPT:
-
Boston University mouse proximal tubule
- BUN:
-
Blood Urea Nitrogen
- CC3:
-
Cleaved caspase-3
- CLP:
-
Cecum ligation and puncture
- CircRNA:
-
Circular RNA
- ceRNA:
-
Competing endogenouse RNA
- HK-2:
-
Human renal tubular epithelial cells
- LPS:
-
Lipopolysaccharide
- PAK7:
-
P21 (RAC1) activated kinase 7
- RT-qPCR:
-
Real-time fluorescence quantitative PCR
- ROC:
-
Receiver operating characteristic
- SA-AKI:
-
Sepsis AKI
References
Manrique-Caballero CL, Del Rio-Pertuz G, Gomez H (2021) Sepsis-associated acute kidney injury. Crit Care Clin 37(2):279–301. https://doi.org/10.1016/j.ccc.2020.11.010
Alobaidi R, Basu RK, Goldstein SL et al (2015) Sepsis-associated acute kidney injury. Semin Nephrol 35(1):2–11. https://doi.org/10.1016/j.semnephrol.2015.01.002
Kashani K, Al-Khafaji A, Ardiles T et al (2013) Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury. Crit Care 17(1):R25. https://doi.org/10.1186/cc12503
Bihorac A, Chawla LS, Shaw AD et al (2014) Validation of cell-cycle arrest biomarkers for acute kidney injury using clinical adjudication. Am J Respir Crit Care Med 189(8):932–939. https://doi.org/10.1164/rccm.201401-0077OC
de Backer D, Donadello K, Taccone FS et al (2011) Microcirculatory alterations: potential mechanisms and implications for therapy. Ann Intensive Care 1(1):27. https://doi.org/10.1186/2110-5820-1-27
Wang Z, Holthoff JH, Seely KA et al (2012) Development of oxidative stress in the peritubular capillary microenvironment mediates sepsis-induced renal microcirculatory failure and acute kidney injury. Am J Pathol 180(2):505–516. https://doi.org/10.1016/j.ajpath.2011.10.011
Gomez H, Kellum JA, Ronco C (2017) Metabolic reprogramming and tolerance during sepsis-induced AKI. Nat Rev Nephrol 13(3):143–151. https://doi.org/10.1038/nrneph.2016.186
Liu X, Xie X, Ren Y et al (2021) The role of necroptosis in disease and treatment. MedComm (2020) 2(4):730–755. https://doi.org/10.1002/mco2.108
Bellomo R, Kellum JA, Ronco C et al (2017) Acute kidney injury in sepsis. Intensive Care Med 43(6):816–828. https://doi.org/10.1007/s00134-017-4755-7
Peerapornratana S, Manrique-Caballero CL, Gomez H et al (2019) Acute kidney injury from sepsis: current concepts, epidemiology, pathophysiology, prevention and treatment. Kidney Int 96(5):1083–1099. https://doi.org/10.1016/j.kint.2019.05.026
Panni S, Lovering RC, Porras P et al (2020) Non-coding RNA regulatory networks. Biochim Biophys Acta Gene Regul Mech 1863(6):194417. https://doi.org/10.1016/j.bbagrm.2019.194417
Jeck WR, Sharpless NE (2014) Detecting and characterizing circular RNAs. Nat Biotechnol 32(5):453–461. https://doi.org/10.1038/nbt.2890
Tian T, Li S, Luo H et al (2023) LILAR, a novel long noncoding RNA regulating autophagy in the liver tissues of endotoxemic mice through a competing endogenous RNA mechanism. MedComm (2020) 4(5):e398. https://doi.org/10.1002/mco2.398
Kristensen LS, Jakobsen T, Hager H et al (2022) The emerging roles of circRNAs in cancer and oncology. Nat Rev Clin Oncol 19(3):188–206. https://doi.org/10.1038/s41571-021-00585-y
Brandenburger T, Salgado Somoza A, Devaux Y et al (2018) Noncoding RNAs in acute kidney injury. Kidney Int 94(5):870–881. https://doi.org/10.1016/j.kint.2018.06.033
Wang L, Bayinchahan B, Zhang D et al (2023) The novel biomarker circ_0020339 drives septic acute kidney injury by targeting miR-17–5p/IPMK axis. Int Urol Nephrol 55(2):437–448. https://doi.org/10.1007/s11255-022-03331-0
Long B, Li N, Xu XX et al (2018) Long noncoding RNA FTX regulates cardiomyocyte apoptosis by targeting miR-29b-1–5p and Bcl2l2. Biochem Biophys Res Commun 495(1):312–318. https://doi.org/10.1016/j.bbrc.2017.11.030
Cotteret S, Jaffer ZM, Beeser A et al (2003) p21-Activated kinase 5 (Pak5) localizes to mitochondria and inhibits apoptosis by phosphorylating BAD. Mol Cell Biol 23(16):5526–5539. https://doi.org/10.1128/MCB.23.16.5526-5539.2003
Wang R, Freywald A, Chen Y et al (2015) Transgenic 4–1BBL-engineered vaccine stimulates potent Gag-specific therapeutic and long-term immunity via increased priming of CD44(+)CD62L(high) IL-7R(+) CTLs with up- and downregulation of anti- and pro-apoptosis genes. Cell Mol Immunol 12(4):456–465. https://doi.org/10.1038/cmi.2014.72
Ouyang X, He Z, Fang H et al (2023) A protein encoded by circular ZNF609 RNA induces acute kidney injury by activating the AKT/mTOR-autophagy pathway. Mol Ther 31(6):1722–1738. https://doi.org/10.1016/j.ymthe.2022.09.007
Liu Z, Wang Y, Shu S et al (2019) Non-coding RNAs in kidney injury and repair. Am J Physiol Cell Physiol 317(2):C177–C188. https://doi.org/10.1152/ajpcell.00048.2019
Chen Y, Jing H, Tang S et al (2022) Non-coding RNAs in sepsis-associated acute kidney injury. Front Physiol 13:830924. https://doi.org/10.3389/fphys.2022.830924
Feng Y, Liu B, Chen J et al (2023) The Circ_35953 induced by the NF-kappaB mediated the septic AKI via targeting miR-7219–5p/HOOK3 and IGFBP7 axis. J Cell Mol Med 27(9):1261–1276. https://doi.org/10.1111/jcmm.17731
Liao Y, Peng X, Li X et al (2022) CircRNA_45478 promotes ischemic AKI by targeting the miR-190a-5p/PHLPP1 axis. FASEB J 36(12):e22633. https://doi.org/10.1096/fj.202201070R
Chen M, Zhang L (2023) Circ_0001806 relieves LPS-induced HK2 cell injury by regulating the expression of miR-942–5p and TXNIP. J Bioenerg Biomembr 55(4):301–312. https://doi.org/10.1007/s10863-023-09978-3
Lu H, Chen Y, Wang X et al (2022) Circular RNA HIPK3 aggravates sepsis-induced acute kidney injury via modulating the microRNA-338/forkhead box A1 axis. Bioengineered 13(3):4798–4809. https://doi.org/10.1080/21655979.2022.2032974
Xu L, Cao H, Xu P et al (2022) Circ_0114427 promotes LPS-induced septic acute kidney injury by modulating miR-495–3p/TRAF6 through the NF-kappaB pathway. Autoimmunity 55(1):52–64. https://doi.org/10.1080/08916934.2021.1995861
Zhang B, You T, Liu Y et al (2023) Circ_0114428 influences the progression of septic acute kidney injury via regulating Mir-370–3p/Timp2 axis. Shock 59(3):505–513. https://doi.org/10.1097/SHK.0000000000002077
Tan Y, Yu Z, Li P et al (2023) Circ_0001714 knockdown alleviates lipopolysaccharide-induced apoptosis and inflammation in renal tubular epithelial cells via miR-129–5p/TRAF6 axis in septic acute kidney injury. J Bioenerg Biomembr 55(4):289–300. https://doi.org/10.1007/s10863-023-09975-6
Cao J, Shi D, Zhu L et al (2021) Circ_RASGEF1B promotes LPS-induced apoptosis and inflammatory response by targeting microRNA-146a-5p/Pdk1 axis in septic acute kidney injury cell model. Nephron 145(6):748–759. https://doi.org/10.1159/000517475
He Y, Sun Y, Peng J (2021) Circ_0114428 regulates sepsis-induced kidney injury by targeting the miR-495–3p/CRBN axis. Inflammation 44(4):1464–1477. https://doi.org/10.1007/s10753-021-01432-z
Li H, Zhang X, Wang P et al (2021) Knockdown of circ-FANCA alleviates LPS-induced HK2 cell injury via targeting miR-93–5p/OXSR1 axis in septic acute kidney injury. Diabetol Metab Syndr 13(1):7. https://doi.org/10.1186/s13098-021-00625-8
Li P, Liu Y, You T (2023) CircNRIP1 knockdown alleviates lipopolysaccharide-induced human kidney 2 cell apoptosis and inflammation through miR-339–5p/OXSR1 pathway. Shock 59(3):426–433. https://doi.org/10.1097/SHK.0000000000002057
Kuang F, Wang B, You T et al (2023) Circ_0001818 targets Mir-136–5p to increase lipopolysaccharide-induced Hk2 cell injuries by activating Txnip/Nlrp3 inflammasome pathway. Shock 60(1):110–120. https://doi.org/10.1097/SHK.0000000000002140
Li Q, Wang T, Wang X et al (2023) Inhibition of sepsis-induced acute kidney injury via the circITCH-miR-579–3p-ZEB2 axis. Environ Toxicol 38(6):1217–1225. https://doi.org/10.1002/tox.23682
Wang F, Zhang F, Tian Q et al (2022) CircVMA21 ameliorates lipopolysaccharide (LPS)-induced HK-2 cell injury depending on the regulation of miR-7–5p/PPARA. Autoimmunity 55(2):136–146. https://doi.org/10.1080/08916934.2021.2012764
You T, Kuang F (2023) Circ_0008882 stimulates Pde7a to suppress septic acute kidney injury progression by sponging Mir-155–5p. Shock 59(4):657–665. https://doi.org/10.1097/SHK.0000000000002093
Tan M, Bei R (2021) Circ_0091702 serves as a sponge of miR-545–3p to attenuate sepsis-related acute kidney injury by upregulating THBS2. J Mol Histol 52(4):717–728. https://doi.org/10.1007/s10735-021-09991-z
Patop IL, Wust S, Kadener S (2019) Past, present, and future of circRNAs. EMBO J 38(16):e100836. https://doi.org/10.15252/embj.2018100836
Li X, Yang L, Chen LL (2018) The biogenesis, functions, and challenges of circular RNAs. Mol Cell 71(3):428–442. https://doi.org/10.1016/j.molcel.2018.06.034
Chen LL (2020) The expanding regulatory mechanisms and cellular functions of circular RNAs. Nat Rev Mol Cell Biol 21(8):475–490. https://doi.org/10.1038/s41580-020-0243-y
Inoue A, Mizushima T, Wu X et al (2018) A miR-29b byproduct sequence exhibits potent tumor-suppressive activities via inhibition of NF-kappaB signaling in KRAS-mutant colon cancer cells. Mol Cancer Ther 17(5):977–987. https://doi.org/10.1158/1535-7163.MCT-17-0850
Gu YF, Kong LT (2021) Inhibiting p21-activated kinase (PAK7) enhances radiosensitivity in hepatocellular carcinoma. Hum Exp Toxicol 40(12):2202–2214. https://doi.org/10.1177/09603271211027948
He S, Feng M, Liu M et al (2014) P21-activated kinase 7 mediates cisplatin-resistance of esophageal squamous carcinoma cells with Aurora-A overexpression. PLoS ONE 9(12):e113989. https://doi.org/10.1371/journal.pone.0113989
Han K, Zhou Y, Gan ZH et al (2014) p21-activated kinase 7 is an oncogene in human osteosarcoma. Cell Biol Int 38(12):1394–1402. https://doi.org/10.1002/cbin.10351
Acknowledgements
The Core Facility for Advanced Light Microscopy at Second Xiangya Hospital. Figures were created using Adobe Photoshop. For help in the technical assistance, I thank Yuqing Feng, Yuxin Xie and Yang Xia.
Funding
The National Natural Science Foundation of China (Grant No. 82171088), State Key Laboratory of Advanced Design and Manufacturing for Vehicle Body (Grant No. 2021SK2034), and the Natural Science Foundation of Hunan Province (Grant No. 2021JJ30935) supported this work.
Author information
Authors and Affiliations
Contributions
XP: Data curation; formal analysis (equal); investigation (equal); writing–original draft. WZ: investigation (equal); software (equal); HL: Funding acquisition (equal); methodology (equal); project administration (equal); resources (equal); supervision (equal); writing – review and editing (equal). DZ: Conceptualization (equal); data curation (equal); project administration (equal); resources (equal); supervision (equal); validation (equal); writing–review and editing (equal).
Corresponding author
Ethics declarations
Conflict of Interest
The authors have no relevant financial or non-financial interests to disclose.
Ethics approval
This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of the Second Xiangya Hospital, Central South University (NO. 2023017). All animal experiments complied with the guiding principles approved by the Animal Care Ethics Committee of Second Xiangya Hospital, People's Republic of Chinae (NO. 2020310).
Consent to participate
Informed consent was obtained from all individual participants included in the study.
Consent to publish
All authors read and approved the final manuscript.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Peng, X., Li, H., Zhang, W. et al. Discovery and verification of mmu_Circ_26986/hsa_Circ_0072463 as a potential biomarker and intervention target for sepsis-associated acute kidney injury. Cell. Mol. Life Sci. 81, 154 (2024). https://doi.org/10.1007/s00018-023-05079-x
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1007/s00018-023-05079-x